Pharmacology and the Nursing Process 9th Edition Linda Lane Lilley, Shelly Rainforth Collins, Julie S. SnyderContents Chapter 01: The Nursing Process and
... [Show More] Drug Therapy ....................................................................................4 Chapter 02: Pharmacologic Principles..........................................................................................................8 Chapter 03: Lifespan Considerations..........................................................................................................14 Chapter 04: Cultural, Legal, and Ethical Considerations.............................................................................20 Chapter 05: Medication Errors: Preventing and Responding .....................................................................26 Chapter 06: Patient Education and Drug Therapy ......................................................................................29 Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements.............................................34 Chapter 08: Gene Therapy and Pharmacogenomics..................................................................................38 Chapter 09: Photo Atlas of Drug Administration........................................................................................41 Chapter 10: Analgesic Drugs.......................................................................................................................50 Chapter 11: General and Local Anesthetics................................................................................................57 Chapter 12: Central Nervous System Depressants and Muscle Relaxants.................................................61 Chapter 13: Central Nervous System Stimulants and Related Drugs.........................................................66 Chapter 14: Antiepileptic Drugs..................................................................................................................70 Chapter 15: Antiparkinson Drugs................................................................................................................76 Chapter 16: Psychotherapeutic Drugs........................................................................................................81 Chapter 17: Substance Use Disorder..........................................................................................................88 Chapter 18: Adrenergic Drugs.....................................................................................................................93 Chapter 19: Adrenergic-Blocking Drugs......................................................................................................98 Chapter 20: Cholinergic Drugs..................................................................................................................103 Chapter 21: Cholinergic-Blocking Drugs ...................................................................................................108 Chapter 22: Antihypertensive Drugs.........................................................................................................113 Chapter 23: Antianginal Drugs..................................................................................................................119 Chapter 24: Heart Failure Drugs ...............................................................................................................125 Chapter 25: Antidysrhythmic Drugs..........................................................................................................131 Chapter 26: Coagulation Modifier Drugs..................................................................................................137 Chapter 27: Antilipemic Drugs..................................................................................................................143 Chapter 28: Diuretic Drugs........................................................................................................................148 Chapter 29: Fluids and Electrolytes..........................................................................................................154 Chapter 30: Pituitary Drugs.......................................................................................................................160 NURSINGTB.COM LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK NURSINGTB.COM Chapter 31: Thyroid and Antithyroid Drugs..............................................................................................163 Chapter 32: Antidiabetic Drugs.................................................................................................................168 Chapter 33: Adrenal Drugs........................................................................................................................177 Chapter 34: Women’s Health Drugs.........................................................................................................181 Chapter 35: Men’s Health Drugs...............................................................................................................188 Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants.........................................193 Chapter 37: Respiratory Drugs..................................................................................................................198 Chapter 38: Antibiotics Part 1...................................................................................................................204 Chapter 39: Antibiotics Part 2...................................................................................................................211 Chapter 40: Antiviral Drugs.......................................................................................................................216 Chapter 41: Antitubercular Drugs.............................................................................................................221 Chapter 42: Antifungal Drugs....................................................................................................................226 Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs...........................................................231 Chapter 44: Anti-inflammatory and Antigout Drugs.................................................................................236 Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs.....................242 Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs.........248 Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs......................................................253 Chapter 48: Immunosuppressant Drugs...................................................................................................258 Chapter 49: Immunizing Drugs .................................................................................................................263 Chapter 50: Acid-Controlling Drugs..........................................................................................................268 Chapter 51: Bowel Disorder Drugs............................................................................................................274 Chapter 52: Antiemetic and Antinausea Drugs ........................................................................................281 Chapter 53: Vitamins and Minerals ..........................................................................................................286 Chapter 54: Anemia Drugs........................................................................................................................292 Chapter 55: Nutritional Supplements.......................................................................................................299 Chapter 56: Dermatologic Drugs ..............................................................................................................304 Chapter 57: Ophthalmic Drugs .................................................................................................................310 Chapter 58: Otic Drugs..............................................................................................................................315The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing diagnosis?The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave the medication 2 hours after the scheduled dose was due. What type of problem does this represent?The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and documenting the patient’s therapeutic response to the medication. Which phase of the nursing process do these actions illustrate?The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. Which statement best illustrates an outcome criterion for this patient?Which activity best reflects the implementation phase of the nursing process for the patient who is newly diagnosed with hypertension?The medication order reads, “Give ondansetron (Zofran) 4 mg, 30 minutes before beginning chemotherapy to prevent nausea.” The nurse notes that the route is missing from the order. What is the nurse’s best action?When the nurse considers the timing of a drug dose, which factor is appropriate to consider when deciding when to give a drug? a. The patient’s ability to swalThe nurse is performing an assessment of a newly admitted patient. Which is an example of subjective data?When giving medications, the nurse will follow the rights of medication administration. The rights include the right documentation, the right reason, the right response, and the patient’s right to refuse. Which of these are additional rights? (Select all that apply.)Place the phases of the nursing process in the correct order, with 1 as the first phase and 5 as the last phase. (Select all that apply.) a. Planning b. Evaluation c. Assessment d. Implementation e. Nursing DiagnosesThe patient is receiving two different drugs. At current dosages and dosage forms, both drugs are absorbed into the circulation in identical amounts. Which term is used to identify this principle? a. Bioequivalent b. Synergistic c. Prodrugs d. Steady stateWhen given an intravenous medication, the patient says to the nurse, “I usually take pills. Why does this medication have to be given in the arm?” What is the nurse’s best answer?6. When administering drugs, the nurse remembers that the duration of action of a drug is defined as which of these? a. The time it takes for a drug to elicit a therapeutic response b. The amount of time needed to remove a drug from circulation c. The time it takes for a drug to achieve its maximum therapeutic response d. The time period at which a drug’s concentration is sufficient to cause a therapeutic response ANS: D Duration of action is the time during which drug concentration is sufficient to elicit a therapeutic response. The other options do not define duration of action. A drug’s onset of action is the time it takes for the drug to elicit a therapeutic response. A drug’s peak effect is the time it takes for the drug to reach its maximum therapeutic response. Elimination is the length of time it takes to remove a drug from circulation. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: General MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 7. When reviewing the mechanism of action of a specific drug, the nurse reads that the drug works by selective enzyme interaction. Which of these processes describes selective enzyme interaction? a. The drug alters cell membrane permeability. b. The drug’s effectiveness within the cell walls of the target tissue is enhanced. c. The drug is attracted to a receptor on the cell wall, preventing an enzyme from binding to that receptor. d. The drug binds to an enzyme molecule and inhibits or enhances the enzyme’s action with the normal target cell. ANS: D With selective enzyme interaction, the drug attracts the enzymes to bind with the drug instead of allowing the enzymes to bind with their normal target cells. As a result, the target cells are protected from the action of the enzymes. This results in a drug effect. The actions described in the other options do not occur with selective enzyme interactions. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: General MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 8. When administering a new medication to a patient, the nurse reads that it is highly protein bound. Assuming that the patient’s albumin levels are normal, the nurse would expect which result, as compared to a medication that is not highly protein bound? a. Renal excretion will be faster. b. The drug will be metabolized quickly. c. The duration of action of the medication will be shorter. d. The duration of action of the medication will be longer. ANS: D NURSINGTB.COM LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK [Show Less]